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With new incentives, some governments in Latin America are starting to increase invest-
ment in basic and applied research. Although the news is encouraging, scientists in this 
region still face many challenges ahead.After the economic crises of the 1990s 
in Latin America, when Argentina’s 
economy minister famously advised 
scientists to go “wash dishes” as a 
career, science in the region is see-
ing better times. Boosted by a 5.6% 
jump in economic growth rate in 
2006, with projections of a 20.6% 
increase in gross domestic product 
(GDP) by 2008 (http://www.eclac.
org/publicaciones/xml/2/29312/
lcg2338i.pdf), and motivated by a 
heartening increase in the number of 
scientific papers published by Latin 
American authors, governments 
(particularly those of Brazil, Argen-
tina, Chile, and Mexico) are announc-
ing new packages and incentives to 
foster science and technology. It is 
hoped that these encouraging devel-
opments and the increased focus 
on science and technology will also 
benefit the rest of the region.
New Legislation to Boost 
Research
Brazil started to increase invest-
ment in science 10 to 15 years ago 
through several initiatives including 
one to increase the number of gradu-
ate school programs, one to sup-
port research centers of excellence 
(PRONEX), and one that introduced 
science and technology grants funded 
by Brazilian companies whose rev-
enues result from the use of natural 
resources (Fundos Setoriais). How-
ever, these initiatives pale in compari-
son to the announcement last month 
by Brazil’s President Luiz Inácio Lula 
da Silva that his government has ear-
marked US $22.9 billion (US $1 = R 
$1.79) to spend on science, technol-
ogy, and innovation over the next 
3 years. His plan focuses on estab-
lishing and consolidating a national system for science, technology, and 
innovation; promoting technological 
innovation in companies and indus-
try; advancing R&D in disciplines 
considered to be promising, such as 
nanotechnology and biotechnology; 
and promoting science and technol-
ogy to society. “It’s a package like no 
other. I don’t think we ever had some-
thing like this in Brazil” says geneticist 
Mayana Zatz, Dean of Research at 
the Universidade de São Paulo, who 
is known for her work on muscular 
dystrophy and for supporting the use 
of embryonic stem cells in research. 
Zatz expects to see “a paradigm shift 
in the way people see and do science 
in Brazil.” Says Rafael Roesler, head 
of the Pharmacology Department at 
Universidade Federal do Rio Grande 
do Sul and a researcher at the Hos-
pital de Clinicas de Porto Alegre, 
“transferring knowledge from our labs 
to industry will be easier now.” For 
Laila Naoum, a molecular biologist 
who recently returned to Brazil after 
spending several years as a postdoc 
at the Marine Biology Laboratory at 
Woods Hole in the United States, the 
new announcement gives her hope for 
finding a permanent position in a Bra-
zilian university or a place in industry. 
“When I was in the US, I wished there 
was some type of bank of opportu-
nities in Brazil for people like me. I 
think that now more opportunities will 
be available and finding a position, I 
hope, will be easier.”
Meanwhile, Cristina Fernández de 
Kirchner, the new President of Brazil’s 
neighbor Argentina, who took office 
several weeks ago, has announced 
the creation of Argentina’s first ever 
Ministry for Science and Technology. 
Until now, science and technology 
have been overseen by offices inte-Cell 131, Decemgrated within a much bigger ministry 
that also included education. Cristina 
Fernández de Kirchner and her gov-
ernment are expected to increase 
investments in science and technol-
ogy to 1% of GDP by 2010 (in 2006, 
investment was 0.58% of GDP) (http://
www.secyt.gov.ar/plan_bicentenario/
documentos_finales/plan_bicente-
nario_publicacion.pdf). Of that pro-
posed 1% GDP, it is expected that 
half will be provided by public funds 
and half by the private sector. Indeed, 
the new government has already 
announced a 20% increase in funding 
for a select list of science and technol-
ogy projects to be launched in 2008. 
The new ministry is to be headed by 
José Lino Barañao, a molecular biol-
ogist known for his work with trans-
genic animals, who was president of 
the National Agency for Scientific and 
Technological Promotion. And his 
message is clear: science and indus-
try need to talk. “If the link between 
science and industry is missing, the 
scientific creativity and knowledge 
end up giving fruits elsewhere… it’s 
like producing petroleum and then 
giving it away,” he said in a statement 
published in Argentina’s daily news-
paper La Nacion. “Dr. Barañao is an 
excellent scientist with great experi-
ence in administration who has clear 
ideas about the role of science and 
technology in a developing country 
and is well respected by the scientific 
community,” says Alberto Kornbliht, a 
professor of molecular and cell biol-
ogy at Universidad de Buenos Aires in 
Argentina and an HHMI International 
Research Scholar. Nevertheless, the 
expectations of Argentinian scientists 
are running high. Says immunologist 
Gabriel Rabinovich, also at Universi-
dad de Buenos Aires, “We hope that ber 28, 2007 ©2007 Elsevier Inc. 1213
Table 1. Expenditure on Science and Technology in Latin America 
Expenditure on Science and 
Technology as % GDP in 2004a
Share of World’s Gross Expenditure 
on R&D (GERD) in 2002b
Total Patent Applications Granted 
Worldwide in 2005c,d
Argentina 0.44 1,798
Brazil 0.91 7,047d
Chile 0.68 637
Mexico 0.41 8,098
Latin America and 
Caribbean
2.6 21,126
North America 37.0
Asia 31.5
Europe 27.3
United States 2.70 35.0 143,806
ahttp://www.ricyt.edu.ar/indicadores/comparativos/05.xls.
bhttp://www.uis.unesco.org/template/pdf/S&T/WdScienceRepTable1.pdf.
chttp://www.ricyt.edu.ar/indicadores/comparativos/22.xls.
dData for 2005 are not available for Brazil; 2004 data are shown.the newly elected President, Cristina 
Fernández de Kirchner, will promote 
a sustained growth of the scientific 
community in Argentina. However, 
much remains to be done in terms of 
increasing scientific competitiveness 
in the region and avoiding excessive 
brain drain of talented South Ameri-
cans to developed countries. That 
includes fostering international col-
laborations, creating stronger ties 
with industry, giving strong support 
in the initial phases of independent 
careers and stimulating public aware-
ness of the importance of scientific 
knowledge for national development.” 
However, Rabinovich does point out 
that “despite serious economic and 
political challenges, a tradition of 
fundamental research has always 
been fostered in Argentina.” Although 
delighted at the recent announce-
ment, both researchers agree that 
there remain many challenges ahead 
for science in Argentina.
Perhaps Cristina Fernández 
de Kirchner’s announce ment was 
inspired by the new president of 
Chile, Michelle Bachelet, who, when 
elected in 2006, promised that inno-
vation and entrepreneurship would 
be one of the main transformations 
of her administration. She announced 
her intention to increase R&D spend-
ing by 50%, which means that by 
2010 the country should be spending 
1% of its GDP on science and tech-1214 Cell 131, December 28, 2007 ©200nology (http://www.conicyt.cl/573/
articles-7931_recurso_1.pdf). Already 
the number of graduate science fel-
lowships has increased by 112% in 
2006 compared to the previous year, 
and for the first time research grants 
have been given to young research-
ers (114 projects total). From 2004 
to 2006, the investment in science 
increased 50% according to a report 
by the National Commission for Sci-
entific and Technological Investiga-
tion (CONOCYT). The investment 
in 2007 is almost twice the amount 
invested in 2004 (http://www.conicyt.
cl/573/article-7395.html).
Further North, in Mexico, a 2006 
report by the National Council for 
Science and Technology (CON-
ACYT) shows progress thanks to a 
special program launched in 2001. 
The number of students enrolled in 
science and technology PhD pro-
grams increased from 488 in 1994 
to 2,009 in 2005, and the number 
of researchers brought under the 
umbrella of the National Science and 
Technology System (in public univer-
sities or centers) increased by 62% 
during the period 2001–2005. The 
2001 program had three goals: to 
establish a state policy on science 
and technology, to increase capac-
ity, and to improve competitiveness 
and innovation. To accomplish these 
goals, the Mexican government 
passed the Science and Technology 7 Elsevier Inc.Law in 2002, which created a spe-
cial fund for science and technology, 
called Sectorial Funds, supported by 
monies from the ministries and other 
governmental agencies, as well as 
from states and districts (mixed 
funds). The Law stated that Vicente 
Fox’s government would need to 
invest 1% of the country’s GDP in sci-
ence by the end of his term in 2006. 
According to a CONACYT report, the 
investment in R&D in 2005 was still 
only 0.43% GDP (http://www.siicyt.
gob.mx/siicyt/docs/Estadisticas3/
Informe2006/Capitulo%205.pdf).
Regional Collaborations
Despite the recent good news, Latin 
America still has a long way to go to 
catch up with developed countries 
(Tables 1 and 2). For example, the 
share of the world’s gross expendi-
ture on R&D (GERD) in 2002 by Latin 
American and Caribbean countries 
was 2.6, while North America’s share 
was 37 and Asia’s share was 31.5 
(see Table 1). In 2004, Brazil invested 
0.91% of its GDP in R&D, while Mex-
ico invested 0.41%, Argentina 0.44%, 
and Chile 0.68% (see Table 1). This 
low investment in R&D has had dra-
matic consequences for a scientific 
community that is constantly strug-
gling with unstable financial condi-
tions, limited numbers of grants and 
low salaries, difficulties importing 
reagents and equipment, and strong 
Table 2. Latin America’s Share of Scientific Publications
Number of Science Papers Published in Science Citation Index (SCI)a
2001 2002 2003 2004 2005
Rank Based on 
# SCI Papers 
1999–2003b
% World Share 
of SCI Papers 
1999–2003b
Argenina 5,309 5,581 5,640 5,499 5,699 29 0.56
Brazil 13,677 15,854 16,324 17,785 18,765 17 1.45
Chile 2,363 2,655 2,972 2,991 3,262 39 0.27
Mexico 5,666 5,995 6,602 7,148 7,541 27 0.65
Latin American 
and Caribbean
30,339 33,577 35,299 36,745 38,729 N/A N/A
United States 316,876 331,538 348,225 363,562 375,401 1 31.48
ahttp://www.ricyt.edu.ar/indicadores/comparativos/26.xls.
bHermes-Loma et al., 2007, International Union of Biochemistry and Molecular Biology Life 59, 1–12.competition for the few permanent 
positions available at public institu-
tions. Due to the general scarcity of 
money for science in Latin America, 
governments and international agen-
cies have strategically funded a few 
groups of excellence doing research 
in priority fields for these countries, 
forming continent-wide and country-
wide collaborative networks.
A good example of a longstand-
ing continent-wide collaboration is a 
network of scientists led by Osvaldo 
Podhajcer at the Institute Leloir in 
Argentina, Guillermo Mazzolini at 
Universidad Austral in Argentina, and 
Martín Montecino at Universidad de 
Concepción in Chile. Together they 
have received US $6 million, princi-
pally from the World Bank, to develop 
new approaches for gene targeting 
based on functional genomics plat-
forms and new viral vectors that tar-
get gastrointestinal cancer, which is 
a particular problem in Chile, where 
the disease kills about 25 of every 
100,000 persons. “Our collaboration 
is essential because our groups have 
complementing skills. Podhajcer’s 
group has expertise in using viral 
particles as vectors for gene therapy, 
our group is expert in the analysis of 
promoters that are tissue-specific, 
and Mazzolini has great experience 
in pharmacological toxicity and clini-
cal trials,” says Montecino. He adds 
that this is the first scientific project 
in the region involving efforts from 
two countries to solve a major health 
problem.Ten years after taking their first 
steps into genomics research, Brazil 
and Mexico have built a consolidated 
network of genome and bioinformat-
ics research centers that have con-
centrated their efforts on sequencing 
expressed sequence tags and the 
genomes of organisms that are of eco-
nomic or health importance for this 
region. For example, together with a 
group in Cuba led by Abel Gonzales 
Perez at the National Bioinformatics 
Center, Julio Collado-Vides at the Cen-
ter for Genomic Sciences at Universi-
dad Nacional Autónoma de México 
(UNAM) and Ana Tereza Ribeiro Vas-
concelos, head of the Bioinformat-
ics branch at the National Laboratory 
of Computer Sciences in Brazil, have 
developed Tractor, a database of com-
putationally predicted transcription 
factor-binding sites in γ-proteobacterial 
genomes. The database now contains 
genome sequences of more than 30 
bacterial species, which the group 
hopes will help in elucidating how bac-
teria respond to environmental changes 
at the level of transcriptional regula-
tion. Collado-Vides’ group is also col-
laborating with the US Department of 
Agriculture and the International Center 
for Tropical Agriculture in Colombia 
to sequence the genome of the tape-
worm Taenia solium and of Phaseolus 
vulgaris, a food staple in Mexico. These 
projects provide valuable biological 
information that may help to improve 
agriculture and health, but the con-
sequences of consolidated genome 
research networks in the region have Cell 131, Deceother benefits. As Ana Tereza Ribeiro 
Vasconcelos points out, these net-
works enable Brazilian scientists “to 
be trained not only in molecular and 
sequencing techniques, but also in bio-
informatics and computational analysis 
of biological information.” Likewise, in 
Mexico, these networks have prompted 
the launch of a new undergraduate 
program at UNAM devoted to training 
personnel in disciplines essential for 
genomic sciences such as mathemat-
ics, statistics, and computer science. 
“We expect the training to be extended 
into a PhD program that can be done 
either here in Mexico or abroad,” says 
Collado-Vides.
Meanwhile, in Brazil, a country-
wide network of research centers 
enabled sequencing of the genome of 
the bacterium Xylella fastidiosa, which 
causes a disease of citrus crops that 
has severe economic ramifications 
given that Brazil produces 30% of 
the world’s citrus crop. Sequencing 
of other economically and medically 
important genomes such as those of 
sugar cane and the parasite Schisto-
soma mansoni, has also been com-
pleted. The next organism to have 
its genome sequenced is Anopheles 
darlingi, which is the vector that trans-
mits malaria in South America.
Current Challenges
Brain Drain
As with most developing regions, brain 
drain remains a problem. According to 
a 2007 OECD report, almost 8% of the 
population living in OECD countries are mber 28, 2007 ©2007 Elsevier Inc. 1215
university-educated people from either 
South or Central America (http://www.
oecd.org/country). Nevertheless, as 
the opportunities for scientists start 
to improve across the region, going 
back home may not be as hard as it 
sounds. After spending 2 years as a 
postdoc at the Center of Drug Evalua-
tion and Research of the US Food and 
Drug Administration (FDA) in Rockville, 
Maryland, Fabio Klamt now has his 
own research group at Universidade 
Federal do Rio Grande do Sul in Brazil. 
The secret he reveals is “when abroad, 
do not lose ties with your institution 
in Brazil.” Now that he is back home, 
Klamt also emphasizes that “I want 
to keep the doors open and not miss 
new opportunities for collaborating 
with my previous lab in the US.” Klamt 
remains confident that “returning home 
is worthwhile.”
The problem of brain drain is par-
ticularly aggravated in Mexico, per-
haps due to its proximity to the United 
States. Researchers at Universidad 
Nacional Autónoma de México esti-
mate that of the 2650 graduate stu-
dents currently abroad and supported 
by Mexican fellowships, only 150 will 
return. To address this imbalance, 
CONACYT has instigated a program 
to repatriate researchers and sup-
ports another program to keep young 
scientists in Mexico. From 2001 to 
2005, the program has resulted in 
845 scientists returning to Mexico.
For well-established scientists, 
however, returning home can be a 
gratifying experience and can also 
enable research that would not be 
possible elsewhere. Take Gerardo 
Jimenez-Sanchez, for example, who 
returned to Mexico from the United 
States after spending several years 
in David Valle’s lab at the Johns Hop-
kins Medical Institutions. He is now 
director of the National Institute of 
Genomic Medicine (INMEGEN) in 1216 Cell 131, December 28, 2007 ©20Mexico City. The principal goal of the 
institute is to assemble a genetic map 
of the Mexican population to discover 
genetic variants (SNPs) associated 
with diabetes, obesity, cancer, and 
heart disease. As Jimenez-Sanchez 
points out, “modern Mexicans are the 
result of a mix of more than 65 native 
Indian groups with Spaniards, lead-
ing to a genetic makeup that is differ-
ent from all other populations.” Initial 
results from the first genetic map of a 
Latin American population that ana-
lyzed the genomes of 1600 individu-
als from 11 different states in Mexico 
indicate that Mexicans have patterns 
of functional SNPs with different fre-
quencies than those observed in other 
populations. Jimenez-Sanchez antici-
pates that “we expect to see dramatic 
effects when applying pharmacog-
enomics to the Mexican population.” 
The genetic map has also attracted 
the interest of food companies seek-
ing to learn how gene variants affect 
the way that food is metabolized and 
the consequences for health. The 
Swiss company, Nestle, recently set 
up a US $0.5 million grant to support 
research and personnel training in 
nutrigenomics at INMEGEN.
Shipping and Handling
Another key problem for scientists in 
Latin America is importing reagents 
and equipment. Despite progress 
seen in specific areas of research, 
small manufacturers in the region 
do not have the capacity to produce 
and deliver reagents and most state-
of-the art equipment. Consequently, 
equipment and consumables must 
be imported from abroad, thus 
increasing the costs of such items. 
Additionally, customs procedures 
related to transporting and storage 
of items that need special handling, 
such as radioactive isotopes, tem-
perature-sensitive molecules, and 
transgenic and knockout animals, 07 Elsevier Inc.are a logistical nightmare. Not to 
mention the time it takes to receive 
imported goods, which can be as 
long as 1 year for sophisticated 
equipment or a month for primers 
that are usually delivered overnight 
in developed countries. Even worse, 
the higher prices of imported items 
are due principally to import duties 
and customs fees that end up being 
paid with public funds as most sci-
entific research in Latin America is 
government funded. A recent sur-
vey conducted in Brazil by the Neu-
roscience and Behavioral Society 
estimated that, on average, 67% of 
the final price paid for items bought 
abroad is spent on importing them. 
Says Brazilian neuroscientist Roesler 
in response to the recent announce-
ment from Lula’s government of the 
windfall for Brazilian science, “more 
money and better funding is always 
welcome, but if I had to change one 
thing to improve science in Brazil that 
would be the bureaucracy associ-
ated with importing research goods.” 
It turns out that Lula is determined to 
address this problem, stating dur-
ing his announcement “…so many 
times a material that in Europe or in 
the United States takes a week to 
be delivered, here it would take any-
where from six months to one year…
as though it were a car or airplane. 
There was no sense of priority.”
Despite the many challenges ahead, 
the future for science in Latin Amer-
ica is looking brighter as evidenced 
by Lula’s tongue-in-cheek comment 
to Science Minister Sergio Rezende 
after the announcement of Brazil’s 
new science package, “I hope you 
do not show up in my office asking 
for money until 2010.” But it will be up 
to the scientists to make the most of 
these promising new developments. 
As Lula points out, “The money is 
available, now make it happen.”
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